Skip to content

Author

Masahito Shimizu

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Limited impact of NLRP3 inflammasome deficiency on diet-induced metabolic dysfunction-associated steatohepatitis in mice

Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive form of metabolic dysfunction-associated steatotic liver disease (MASLD) and a growing cause of chronic liver disease worldwide. Although the NLRP3 inflammasome has been implicated in MASH pathogenesis, its contribution remains controversial acros...

Daisuke Taguchi, Y. Shirakami, Toshihide Maeda et al. · 0 citations
Open access Aug 2026

P1.127. A Case of Unresectable Advanced Esophageal Cancer Successfully Treated With ICI Regimen and RIC

Examples of multidisciplinary treatment are presented, including the selection of an ICI regimen, treatment for irAEs by multiple medical departments, and RIC, in the treatment of esophageal cancer with a large amount of unresectable advanced tumor, as these are highly suggestive.

Yoshihiro Tanaka, Noya Masuda, Jyun Takada et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.